Remove Assay Development Remove Pharmacokinetics Remove Presentation
article thumbnail

The essential role of recombinant phage display antibody libraries

Drug Target Review

These assays may include pharmacokinetic (PK) assays, which provide information on the drug’s properties, and immunogenicity assays for the detection of anti-drug antibodies (ADA), which can lead to adverse events and reduced efficacy. Adapted from Harth S et al. (8) 8) under a CC BY-NC-ND 4.0. 2011 Oct 1;413(1):261–78.

article thumbnail

Article EMA Thank You EMA finalizes clinical anticancer therapeutic guidance update

Agency IQ

The protocol and statistical analysis plan should clearly specify the plans for specimen collection, sample analysis and related clinical outcomes depending on the biomarker assay development and validation strategy. A related question: Which standard of care should be chosen for global master protocols? medical practice.